Mandate

Vinge has advised Litorina V in connection with its acquisition of the Bergfalk group

January 23, 2018

Vinge has advised Litorina V in connection with its acquisition of the Bergfalk group, a leading Swedish distributor within fresh food with focus on meat, fish and shellfish.

The company has a turnover of over SEK 500 million and offers its products in Sweden and Finland. Bergfalk’s former main owners and management will remain as significant owners going forward.

Vinge’s team consisted of partner Jonas Johansson together with the associates Johanna Wiberg and Edin Agic (M&A), Sara Strandberg and Lisa Sennerby (employment), Josefine Lanker (bank & finance), Adriana Berglund and Hayaat Ibrahim (commercial agreements), and Johan Cederblad (environment). Johan Wahlbom provided competition law advice.

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024